Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results.

Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results.
复制标题

DOI:
10.3389/fonc.2022.835549
复制
发表时间:
2022
影响因子:
4.7
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

下一代测序和生物信息学分析已经清楚地揭示了线粒体核糖体基因在癌症发展中的作用。线粒体核糖体由线粒体DNA编码的3个RNA组分和核DNA编码的82个特定蛋白质组分组成。它们合成线粒体内膜氧化磷酸化(OXPHOS)相关蛋白,通过调节能量代谢和细胞凋亡参与多种生物学活动。线粒体核糖体基因与癌症患者的预后和病灶转移等临床特征密切相关。相应地,线粒体核糖体已成为癌症研究的重要焦点。我们综述了生物信息学研究的最新进展,这些研究探索了线粒体核糖体与癌症之间的联系,重点是线粒体核糖体基因作为癌症生物标志物的潜力。
Next-generation sequencing and bioinformatics analyses have clearly revealed the roles of mitochondrial ribosomal genes in cancer development. Mitochondrial ribosomes are composed of three RNA components encoded by mitochondrial DNA and 82 specific protein components encoded by nuclear DNA. They synthesize mitochondrial inner membrane oxidative phosphorylation (OXPHOS)-related proteins and participate in various biological activities via the regulation of energy metabolism and apoptosis. Mitochondrial ribosomal genes are strongly associated with clinical features such as prognosis and foci metastasis in patients with cancer. Accordingly, mitochondrial ribosomes have become an important focus of cancer research. We review recent advances in bioinformatics research that have explored the link between mitochondrial ribosomes and cancer, with a focus on the potential of mitochondrial ribosomal genes as biomarkers in cancer.
DOI: 10.7150/ijms.50782
发表时间: 2021
影响因子: 3.6
作者:
Zhuang L;Meng Z;Yang Z
通讯作者: Yang Z
DOI: 10.1126/science.aaa1193
发表时间: 2015-04-03
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Amunts A;Brown A;Toots J;Scheres SHW;Ramakrishnan V
通讯作者: Ramakrishnan V
甲基-CPG结合结构域测序揭示了神经母细胞瘤中的预后甲基化特征。
DOI: 10.18632/oncotarget.6477
发表时间: 2016-01-12
期刊: Oncotarget
影响因子: --
作者:
Decock A;Ongenaert M;Cannoodt R;Verniers K;De Wilde B;Laureys G;Van Roy N;Berbegall AP;Bienertova-Vasku J;Bown N;Clément N;Combaret V;Haber M;Hoyoux C;Murray J;Noguera R;Pierron G;Schleiermacher G;Schulte JH;Stallings RL;Tweddle DA;Children’s Cancer and Leukaemia Group (CCLG);De Preter K;Speleman F;Vandesompele J
通讯作者: Vandesompele J
DOI: 10.1097/md.0000000000021478
发表时间: 2020-08-07
期刊: Medicine
影响因子: 1.6
作者:
Dai D;Shi R;Han S;Jin H;Wang X
通讯作者: Wang X
DOI: 10.1016/j.bbagrm.2011.11.009
发表时间: 2012-09
影响因子: 4.7
作者:
Christian, Brooke E.;Spremulli, Linda L.
通讯作者: Spremulli, Linda L.